ONTOGENY OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1, PROTEIN-2, AND PROTEIN-3 - QUANTITATIVE MEASUREMENTS BY RADIOIMMUNOASSAY IN HUMAN FETAL SERUM

被引:65
作者
BANG, P
WESTGREN, M
SCHWANDER, J
BLUM, WF
ROSENFELD, RG
STANGENBERG, M
机构
[1] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT OBSTET & GYNECOL,STOCKHOLM,SWEDEN
[2] STANFORD UNIV,SCH MED,DEPT PEDIAT,DIV ENDOCRINOL,STANFORD,CA 94305
[3] KANTONSSPITAL,DEPT INTERNAL MED,CH-4031 BASEL,SWITZERLAND
[4] UNIV TUBINGEN,DEPT PEDIAT,TUBINGEN,GERMANY
关键词
D O I
10.1203/00006450-199410000-00020
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
There is evidence for a role for IGF-I in the endocrine control of human fetal growth despite the low serum IGF-I concentrations. The formation in serum of binary complexes between IGF-I or -II and either of six IGF binding proteins (IGFBP-1 to -6) and, in particular, of long-lived ternary complexes between IGF-I or -II, IGFBP-3, and acid-labile subunit is thought to regulate IGF-I bioavailability by increasing its serum half-life. The present study assesses the bioavailability of circulating IGF-I in 19- to 35-wk gestation human fetuses in utero 1) by quantitative RIA measurements of IGF and IGFBP in serum and 2) by examining whether serum proteolysis of IGFBP-3 may further increase IGF-I bioavailability. Fetal serum concentrations of IGFBP-3, IGF-I, and IGF-II were low with marked or only modest increases with gestational age (p < 0.001, p < 0.005, and p < 0.05, respectively). The mean molar ratio between IGF-I plus -II and IGFBP-3 demonstrated a molar excess of IGF (50%) similar to that in adolescents but in contrast to the 1:1 molar ratio in adults. The median IGFBP-2 concentration was 3-fold elevated to a molar concentration similar to that of IGFBP-3 (adult serum displays 10-fold higher IGFBP-3 concentrations). The median serum IGFBP-1 concentration was not elevated as previously reported in newborns. IGFBP-3 protease activity was not increased in fetal serum, in contrast to pregnancy serum and amniotic fluid. Nevertheless, IGFBP-3 protease activity did interfere with IGFBP-3 determinations by Western ligand blotting, and IGFBP-1 and IGFBP-2 levels obtained by this technique did not correlate with concentrations determined by RIA, stressing the importance of quantitative IGFBP measurements. In summary, increased IGF-I bioavailability in the human fetus is suggested by the molar excess of IGF over IGFBP-3 and the increase in IGFBP-2, which do not form a long-lived ternary complex. The lack of suppression of fetal serum IGFBP-1 may suggest that the delivery of IGF-I to the tissues is normal.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 55 条
[1]   INSULIN-LIKE GROWTH-FACTORS (IGF)-1 AND (IGF)-2 IN HUMAN-FETAL PLASMA AND RELATIONSHIP TO GESTATIONAL-AGE AND FETAL SIZE DURING MIDPREGNANCY [J].
ASHTON, IK ;
ZAPF, J ;
EINSCHENK, I ;
MACKENZIE, IZ .
ACTA ENDOCRINOLOGICA, 1985, 110 (04) :558-563
[2]   INCREASED PROTEOLYSIS OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3) IN NONINSULIN-DEPENDENT DIABETES-MELLITUS SERUM, WITH ELEVATION OF A 29-KILODALTON (KDA) GLYCOSYLATED IGFBP-3 FRAGMENT CONTAINED IN THE APPROXIMATELY 130-KDA TO 150-KDA TERNARY COMPLEX [J].
BANG, P ;
BRISMAR, K ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1119-1127
[3]   FASTING AFFECTS SERUM INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS DIFFERENTLY IN PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS VERSUS HEALTHY NONOBESE AND OBESE SUBJECTS [J].
BANG, P ;
BRISMAR, K ;
ROSENFELD, RG ;
HALL, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :960-967
[4]   COMPARISON OF ACID ETHANOL EXTRACTION AND ACID GEL-FILTRATION PRIOR TO IGF-I AND IGF-II RADIOIMMUNOASSAYS - IMPROVEMENT OF DETERMINATIONS IN ACID ETHANOL EXTRACTS BY THE USE OF TRUNCATED IGF-I AS RADIOLIGAND [J].
BANG, P ;
ERIKSSON, U ;
SARA, V ;
WIVALL, IL ;
HALL, K .
ACTA ENDOCRINOLOGICA, 1991, 124 (06) :620-629
[5]  
BANG P, 1993, ACTA ENDOCRINOL-COP, V128, P397
[6]   TISSUE LOCALIZATION OF PERFUSED ENDOTHELIAL-CELL IGF BINDING-PROTEIN IS MARKEDLY ALTERED BY ASSOCIATION WITH IGF-I [J].
BAR, RS ;
BOES, M ;
DAKE, BL ;
SANDRA, A ;
BAYNE, M ;
CASCIERI, M ;
BOOTH, BA .
ENDOCRINOLOGY, 1990, 127 (06) :3243-3245
[7]  
BAR RS, 1990, ENDOCRINOLOGY, V127, P496
[9]   LEVELS OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN HUMAN CORD BLOOD [J].
BENNETT, A ;
WILSON, DM ;
LIU, F ;
NAGASHIMA, R ;
ROSENFELD, RG ;
HINTZ, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) :609-612
[10]   PLASMA-LEVELS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1, AND GROWTH-HORMONE BINDING-PROTEIN ACTIVITY FROM BIRTH TO THE 3RD MONTH OF LIFE [J].
BERNARDINI, S ;
SPADONI, GL ;
POVOA, G ;
BOSCHERINI, B ;
HALL, K .
ACTA ENDOCRINOLOGICA, 1992, 127 (04) :313-318